George Painter

Dr. George Painter is a founder of and President and CEO of Chimerix Inc. Chimerix is a biotechnology company focused on the discovery and development of orally active anti infective and anti proliferative drugs located in Research Triangle Park, NC. He has twenty-four years of experience in the discovery and development of antiviral agents, and most recently held the position of Executive Vice President, Research and Development, at Triangle Pharmaceuticals where he was a member of the founding management team. In addition to his management experience at Triangle Pharmaceuticals, Dr. Painter held positions at Burroughs Wellcome Co. beginning in 1983 including Director of Chemistry and Director of Virology. Subsequently, he served as Director of Research Process and International Deputy Therapeutic Head for Antiviral Research at GlaxoWellcome Inc. Dr. Painter is a co-inventor of over forty-five patents, six of which have led to approved commercially available drugs or combinations of drugs for the treatment of HIV and hepatitis B. He has led international teams, which generated data for nine investigational new drug applications and three new drug applications. Dr. Painter earned a B.S. in chemistry, an M.S. in physical organic chemistry and a Ph.D. in synthetic chemistry from Emory University. He completed post-doctoral studies at California Institute of Technology in chemistry, and at the University of Miami, School of Medicine in cell biology.